Stockscreener 앱 받기
1.33
22.22%
-0.38
시간 외 거래:
1.36
0.03
+2.26%
전일 마감가:
$1.71
열려 있는:
$1.69
하루 거래량:
501.62K
Relative Volume:
3.11
시가총액:
$4.58M
수익:
$895.50K
순이익/손실:
$-26.30M
주가수익비율:
-0.811
EPS:
-1.64
순현금흐름:
$-23.84M
1주 성능:
-34.80%
1개월 성능:
-6.34%
6개월 성능:
-78.16%
1년 성능:
-91.89%
1일 변동 폭
$1.30
$1.74
1주일 범위
$1.30
$2.07
52주 변동 폭
$1.30
$18.40
Mainz Biomed N V Stock (MYNZ) Company Profile
MYNZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.33 | 6.52M | 895.50K | -26.30M | -23.84M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
463.04 | 176.55B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.09 | 141.18B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
535.54 | 42.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.50 | 32.61B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
182.45 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-14 | 개시 | Maxim Group | Buy |
| 2024-11-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | 개시 | H.C. Wainwright | Buy |
Mainz Biomed N V 주식(MYNZ)의 최신 뉴스
What are Mainz Biomed N.V. company’s key revenue driversDaily Trading Outlook With Proven Results - jammulinksnews.com
Chartists See Breakout Potential in Mainz Biomed N.V.Real Trader Watchlist of Hot Stocks Released - metal.it
What is Mainz Biomed N.V. company’s growth strategyPost Market Review For 2025 - jammulinksnews.com
What is the risk reward ratio of investing in Mainz Biomed N.V. stockStock Market Recommendation With Low Risk - jammulinksnews.com
Why Mainz Biomed N.V. stock attracts strong analyst attentionROI Boosting Trade Opportunity Calendar Published - metal.it
What institutional investors are buying Mainz Biomed N.V. stockTop Growth Opportunities For Fast Growth - jammulinksnews.com
How does Mainz Biomed N.V. compare to its industry peersExplosive wealth accumulation - jammulinksnews.com
Does Mainz Biomed N.V. stock perform well during market downturnsAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
What are the technical indicators suggesting about Mainz Biomed N.V.Stay ahead with advanced stock screening tools - jammulinksnews.com
What catalysts could drive Mainz Biomed N.V. stock higher in 2025Achieve superior returns through strategic trading - jammulinksnews.com
What is the dividend policy of Mainz Biomed N.V. stockBuild wealth steadily with smart trading - jammulinksnews.com
How strong is Mainz Biomed N.V. company’s balance sheetFree Stock Market Return Analysis - jammulinksnews.com
Why is Mainz Biomed N.V. stock attracting strong analyst attentionHigh-yield trading alerts - jammulinksnews.com
What institutions are buying Mainz Biomed N.V. stock nowFree Stock Market Swing Trading Strategies - metal.it
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com
Does Mainz Biomed N.V. stock pay reliable dividendsRapid capital growth - jammulinksnews.com
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - jammulinksnews.com
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
Mainz Biomed, CARE announce collaboration agreement - TipRanks
Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire
Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan
Rockford Register Star: Local News, Politics & Sports in Rockford, IL - FinancialContent
When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com
What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com
Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com
Mainz Biomed N V (MYNZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
2.95%
자본화:
|
볼륨(24시간):